Figure 10
(A–D) The infiltration of four immune cells with significant differences in high- and low-risk groups. (E–G) Association of 9-IRlncRNA signature with several immunotherapy-related markers. (H) The qPCR analysis of expression levels of 9 IRlncRNAs in NCM460, HCT116 and SW480 cell lines; * P<0.05, ** P<0.01, and *** P<0.001.
Association of the 9-IRlncRNA signature with tumor-infiltrating immune cells and its ability to predict immunotherapy response

(A–D) The infiltration of four immune cells with significant differences in high- and low-risk groups. (E–G) Association of 9-IRlncRNA signature with several immunotherapy-related markers. (H) The qPCR analysis of expression levels of 9 IRlncRNAs in NCM460, HCT116 and SW480 cell lines; * P<0.05, ** P<0.01, and *** P<0.001.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept